NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN)

NeuroSense Therapeutics Ltd. is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases, particularly those that affect human cognition and function, such as Alzheimer's and Parkinson's diseases

The company leverages advanced research and proprietary technologies to discover and create novel treatment options aimed at addressing the unmet medical needs of patients suffering from these debilitating conditions. Through its comprehensive approach, NeuroSense aims to improve the quality of life for individuals affected by neurodegenerative disorders while advancing the field of neuroscience.